期刊
TRANSPLANT INTERNATIONAL
卷 27, 期 2, 页码 E8-E12出版社
WILEY-BLACKWELL
DOI: 10.1111/tri.12224
关键词
antibody-mediated rejection; bronchiolitis obliterans; donor-specific antibody; living-donor lobar lung transplantation; retransplantation
资金
- Grants-in-Aid for Scientific Research [23590424] Funding Source: KAKEN
Living-donor lobar lung transplantation (LDLLT) is an established therapy for patients with end-stage lung disease, but living-donor lobar lung retransplantation (re-LDLLT) is rarely reported. We previously reported a case of unilateral antibody-mediated rejection after LDLLT in the presence of newly formed donor-specific antibodies against a right-lobe donor. The same patient developed contralateral bronchiolitis obliterans, resulting in bilateral bronchiolitis obliterans, but re-LDLLT was successful. Pathological findings of the explanted lungs were consistent with the clinical course of the patient. One year after re-LDLLT, the patient is doing well without any anti-human leukocyte antigen antibodies. Four lobes from four different donors were transplanted in this patient. The first two lobes were rejected eventually, but the two lobes implanted later presented no signs of rejection at least for 1year after the transplant. Herein, we report this rare case and compare the clinical course and pathological findings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据